Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | ADC payloads to Fc mutations: advancing bioanalysis for novel modalities 14 days 9 hours 1 mins 4 secs REGISTER NOW!

An interview with Scott Summerfield: Emerging technologies in the bioanalytical field

6 Dec 2017
General interest

For our Spotlight on emerging technologies, we spoke to Scott Summerfield, Worldwide Head of Bioanalysis at GSK (Brentford, UK) about some of the technologies emerging in the bioanalytical field, the advantages and challenges faced with these techniques, and the scope for these technologies to advance further.

Back to our Spotlight – Emerging technologies: DMPK and bioanalysis of small molecules

 

Top content

  • Small molecule method development strategies with Chad Christianson
  • New AI tool predicts multiple sclerosis drug response
  • Waters upgrade Xevo MRT performance: who doesn’t want sharper, faster imaging?

Related tags

emerging technologies interview video
Previous article Next article

Related articles

9 DEC 2019 ADVANCED THERAPIES
Cannabis: the challenges and controversies
4 MAY 2020 JOURNAL ARTICLES
Perspectives on the draft ICH M10 guidance: an interview with Mark Arnold
30 MAR 2020 AN AUTHOR'S PERSPECTIVE
A solvent-free future? Solid-phase microextraction with Janusz Pawliszyn
5 JAN 2018 NEWS
2017 review – top 5 features on Bioanalysis Zone
1 FEB 2024 AWARENESS
Black History Month: an interview with Lauren Bailey
5 OCT 2017 AN AUTHOR'S PERSPECTIVE
An author’s perspective: Gary Van Berkel on immediate drop on demand technology coupled with mass spectrometry
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone